Atlas Trials

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Clinical trial NCT03962283 · UNKNOWN

Trial details

NCT number
NCT03962283
Sponsor
Chinese University of Hong Kong
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Small Bowel DiseaseRifaximin
Start date
2019-08-02
Primary completion
2022-06-30
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.